Testing effectiveness (Phase 2)Ended earlyNCT03267680
What this trial is testing
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3
Who this might be right for
Cervical Squamous Cell Carcinoma In SituVulvar High Grade Squamous Intraepithelial Lesion
University of Southern California 10